MitoSense, Inc.
PrivateLast Round
Seed
Jan 26, 2024
Total Funding Raised
$3.5M
Company Overview
MitoSense, Inc. is a biotechnology company that develops treatments for neurodegenerative diseases using its proprietary Mitochondria Organelle Transplantation (MOT) technology to replenish mitochondria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoSense, Inc. Comparables
Compare MitoSense, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mitrix Bio | 84% | |
| PAEAN Biotechnology | 81% | |
| LUCA Science | 79% |
MitoSense, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 26, 2024 | ||||
| Seed | Feb 8, 2023 |
MitoSense, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Caydan Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2024
Raised $2M in a Seed round.
Recent news
Latest coverage and updates
- partners_withJul 23, 2026
MitoSense, Inc. partnered with Aquilahealth on Jul 23rd '26.
- partners_withJul 13, 2026
MitoSense, Inc. partnered with Pitt on Jul 13th '26.
MitoSense, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MitoSense, Inc.'s valuation, stock price, and market status.
Is MitoSense, Inc. a public or private company?
MitoSense, Inc. is a private company.
What is the current stock price of MitoSense, Inc.?
MitoSense, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is MitoSense, Inc. worth (valuation)?
Valuation information for MitoSense, Inc. is not publicly available.
Can I buy MitoSense, Inc. stock?
MitoSense, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MitoSense, Inc.'s last funding round?
MitoSense, Inc.'s most recent funding round was Seed on January 26, 2024.
Who are the main investors in MitoSense, Inc.?
Key investors in MitoSense, Inc. include Caydan Capital Partners.
Will MitoSense, Inc. IPO soon?
No public IPO plans have been announced for MitoSense, Inc..
How can I track MitoSense, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MitoSense, Inc.'s secondary market activity and sign up for updates.